https://orcid.org/0000-0003-2848-6121
Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Elaine Tan & Ibrahim Halil Sahin. (2021) Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches. Expert Review of Gastroenterology & Hepatology 15:7, pages 735-742.
Read now
Read now
Amanda N. Lisby, John C. Flickinger$suffix/text()$suffix/text(), Babar Bashir, Megan Weindorfer, Sanjna Shelukar, Madison Crutcher, Adam E. Snook & Scott A. Waldman. (2021) GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer. Expert Review of Precision Medicine and Drug Development 6:2, pages 117-129.
Read now
Read now
Articles from other publishers (26)
Bo Song, Hai Hu, Li Zhang, Su-Juan Ye, Yong-Dong Jin, Chang-Ling Shang, Jun Zhang, Hao Sun, Ke Zhang, Bo Yi, Yun-Wei Han & Jin Yan. (2023) Efficacy and safety of anlotinib plus XELOX regimen as first-line therapy for mCRC: a single-arm, multicenter, phase II study (ALTER-C-001). Frontiers in Oncology 13.
Crossref
Crossref
Sisi Ye, Li Bai, Yujuan Qi, Yongdong Jin, Yang Yang, Feixue Song, Ping Gong & Tingting Zhang. (2023) Retrospective analysis of colorectal cancer patients with metachronous initially unresectable liver metastases (and no other) achieving no evidence of disease after first-line comprehensive therapy: a multicenter real-world study. Journal of Cancer Research and Clinical Oncology 149:11, pages 8403-8413.
Crossref
Crossref
Joao Manzi, Camilla O. Hoff, Raphaella Ferreira, Agustin Pimentel, Jashodeep Datta, Alan S. Livingstone, Rodrigo Vianna & Phillipe Abreu. (2023) Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives. Cancers 15:11, pages 3023.
Crossref
Crossref
Li Ren, Dexiang Zhu, Jin Gu, Baoqing Jia, Jin Li, Xinyu Qin, Xishan Wang, Ruihua Xu, Yingjiang Ye, Suzhan Zhang, Zhongtao Zhang, Jianmin Xu & Jia Fan. (2023) Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023). Clinical Surgical Oncology 2:2, pages 100013.
Crossref
Crossref
Ibrahim Halil Sahin, Janie Zhang, Turcin Saridogan, Vikram Gorantla, John Rhree, Monica Malhotra, Roby Thomas, Dennis Hsu & Anwaar Saeed. (2023) Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future. JCO Oncology Practice 19:5, pages 251-259.
Crossref
Crossref
Kun Shang, Nina Ma, Juanjuan Che, Huihui Li, Jiexuan Hu, Haolin Sun & Bangwei Cao. (2023) SLC27A2 mediates FAO in colorectal cancer through nongenic crosstalk regulation of the PPARs pathway. BMC Cancer 23:1.
Crossref
Crossref
Tomokazu Ohishi, Mika K. Kaneko, Yukihiro Yoshida, Atsuo Takashima, Yukinari Kato & Manabu Kawada. (2023) Current Targeted Therapy for Metastatic Colorectal Cancer. International Journal of Molecular Sciences 24:2, pages 1702.
Crossref
Crossref
Yu-An Chien, Hsiu-Chuan Chou, Chu-Chun Yang, Yi-Shiuan Wang, Yu-Shan Wei & Hong-Lin Chan. (2022) Proteomic Analysis of Tumor-specific Biomarkers in Colon Cancer. Current Proteomics 19:4, pages 323-343.
Crossref
Crossref
Canan Karan, Elaine Tan, Humaira Sarfraz, Todd C. Knepper, Christine M. Walko, Seth Felder, Richard Kim & Ibrahim Halil Sahin. (2022) Human Epidermal Growth Factor Receptor 2–Targeting Approaches for Colorectal Cancer: Clinical Implications of Novel Treatments and Future Therapeutic Avenues. JCO Oncology Practice 18:8, pages 545-554.
Crossref
Crossref
Ibrahim Halil Sahin, Kristen K. Ciombor, Luis A. Diaz, James Yu & Richard Kim. (2022) Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues. American Society of Clinical Oncology Educational Book:42, pages 242-253.
Crossref
Crossref
Xiaowei Cao, Shengjie Ge, Xinyu Zhou, Yu Mao, Yue Sun, Wenbo Lu & Menglin Ran. (2022) A dual-signal amplification strategy based on pump-free SERS microfluidic chip for rapid and ultrasensitive detection of non-small cell lung cancer-related circulating tumour DNA in mice serum. Biosensors and Bioelectronics 205, pages 114110.
Crossref
Crossref
Timothy Lewis CannonMD.MD., Jamie N RandallBA.BA., Ethan S. SokolPhD.PhD., Sonja M. Alexander, Raymond C. WadlowMD.MD., Arthur A. WinerMD.MD., Daniel M. BarnettMD.MD., Danny L. RayesBS.BS., Halla S. NimeiriMD.MD. & Kimberly A. McGregorMDMD. (2022) Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS. Cancer Treatment and Research Communications 32, pages 100569.
Crossref
Crossref
Ibrahim Halil Sahin & Jim Klostergaard. (2021)
BRAF
Mutations as Actionable Targets: A Paradigm Shift in the Management of Colorectal Cancer and Novel Avenues
. JCO Oncology Practice 17:12, pages 723-730.
Crossref
Crossref
Yihebali Chi, Yongqian Shu, Yi Ba, Yuxian Bai, Baoli Qin, Xiuwen Wang, Jianping Xiong, Nong Xu, Helong Zhang, Jianfeng Zhou, Jianming Xu, Ying Cheng, Jifeng Feng, Chunhong Hu, Yigui Chen, Zhendong Chen, Jufeng Wang, Chengxue Dang, Jianhong Wang, Yiye Wan, Yong Tang, Donglin Wang, Jiang liu, Minhui Wu, Yanhong Deng, Xingwen Li, Yongqiang Li, Jian Dong, Da Jiang, Guisheng Li, Qiong Wu, Jin Li, Yujuan Qi, Yongkun Sun & Jianqiang Cai. (2021) Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703). The Oncologist 26:10, pages e1693-e1703.
Crossref
Crossref
Lei Zhu, Yuqin Zheng, Tao Wu, Jiaxing He, Xiongchao Fang, Shuai Zhou, Ke Wang & Nan Wang. (2021) Immune-related genes STIM1, ITPKC and PELI1 polymorphisms are associated with risk of colorectal cancer. European Journal of Cancer Prevention 30:5, pages 357-363.
Crossref
Crossref
Elena Maccaroni, Riccardo Giampieri, Edoardo Lenci, Laura Scortichini, Francesca Bianchi, Laura Belvederesi, Cristiana Brugiati, Silvia Pagliaretta, Elisa Ambrosini & Rossana Berardi. (2021) BRCA mutations and gastrointestinal cancers: When to expect the unexpected?. World Journal of Clinical Oncology 12:7, pages 565-580.
Crossref
Crossref
Guido Giordano, Pietro Parcesepe, Giuseppina Bruno, Annamaria Piscazzi, Vincenzo Lizzi, Andrea Remo, Massimo Pancione, Mario Rosario D’Andrea, Elena De Santis, Luigi Coppola, Michele Pietrafesa, Alberto Fersini, Antonio Ambrosi & Matteo Landriscina. (2021) Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era. International Journal of Molecular Sciences 22:14, pages 7717.
Crossref
Crossref
Ana João Pissarra, Catarina Abreu, André Mansinho, Ana Lúcia Costa, Sara Dâmaso, Soraia Lobo-Martins, Marta Martins & Luís Costa. 2021. Colorectal Cancer. Colorectal Cancer.
Cristina Galindo-Pumariño, Manuel Collado, Mercedes Herrera & Cristina Peña. (2021) Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients’ Outcome. Cancers 13:5, pages 1130.
Crossref
Crossref
Nerethika Ravichandiran, Muneesh Kumar Barman, Sai Tejaswi Lavuri, Manjita Srivastava, Shalini Sakthivel, Meenakshi Singh, Kailash Chand, Subash C. Sonkar & Prudhvilal Bhukya. 2021. Handbook of Research on Advancements in Cancer Therapeutics. Handbook of Research on Advancements in Cancer Therapeutics
433
466
.
Anna-Lena Scherr, Andreas Mock, Georg Gdynia, Nathalie Schmitt, Christoph E. Heilig, Felix Korell, Praveen Rhadakrishnan, Paula Hoffmeister, Klaus H. Metzeler, Klaus Schulze-Osthoff, Anna L. Illert, Melanie Boerries, Jörg Trojan, Oliver Waidmann, Johanna Falkenhorst, Jens Siveke, Philipp J. Jost, Michael Bitzer, Nisar P. Malek, Loredana Vecchione, Ivan Jelas, Benedikt Brors, Hanno Glimm, Albrecht Stenzinger, Svetlana P. Grekova, Tobias Gehrig, Henning Schulze-Bergkamen, Dirk Jäger, Peter Schirmacher, Mathias Heikenwalder, Benjamin Goeppert, Martin Schneider, Stefan Fröhling & Bruno C. Köhler. (2020) Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer. Cell Death & Disease 11:10.
Crossref
Crossref
Elie Rassy & Nicholas Pavlidis. (2020) Progress in refining the clinical management of cancer of unknown primary in the molecular era. Nature Reviews Clinical Oncology 17:9, pages 541-554.
Crossref
Crossref
Daniele Frisone, Alex Friedlaender, Umberto Malapelle, Giuseppe Banna & Alfredo Addeo. (2020) A BRAF new world. Critical Reviews in Oncology/Hematology 152, pages 103008.
Crossref
Crossref
Stanislav Filip, Veronika Vymetalkova, Jiri Petera, Ludmila Vodickova, Ondrej Kubecek, Stanislav John, Filip Cecka, Marketa Krupova, Monika Manethova, Klara Cervena & Pavel Vodicka. (2020) Distant Metastasis in Colorectal Cancer Patients—Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review. International Journal of Molecular Sciences 21:15, pages 5255.
Crossref
Crossref
Ibrahim Halil Sahin. (2020) Precision medicine for gastrointestinal cancers: a conference report. Future Science OA 6:6.
Crossref
Crossref
Ibrahim Halil Sahin. (2019) Fine-tuning immunotherapy in MMR-D/MSI-H colorectal cancer. Colorectal Cancer 8:4, pages CRC12.
Crossref
Crossref